Diabetes & Vascular Disease Research

Scope & Guideline

Fostering collaboration for a healthier future in diabetes care.

Introduction

Delve into the academic richness of Diabetes & Vascular Disease Research with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1479-1641
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationDIABETES VASC DIS RE / Diabetes Vasc. Dis. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Diabetes & Vascular Disease Research' focuses on the intersection of diabetes and vascular health, emphasizing research that explores the relationships between diabetes, cardiovascular diseases, and related complications. Its scope encompasses clinical studies, epidemiological research, and molecular investigations aimed at understanding the mechanisms underlying these conditions and improving patient outcomes.
  1. Diabetes and Cardiovascular Disease Interactions:
    Researching the impact of diabetes on cardiovascular health, including the prevalence of heart disease among diabetic patients and mechanisms of cardiovascular complications.
  2. Microvascular and Macrovascular Complications:
    Exploring the pathophysiology, risk factors, and treatment approaches for complications associated with diabetes, such as diabetic nephropathy, retinopathy, and peripheral artery disease.
  3. Innovative Therapeutic Approaches:
    Investigating new medications, treatment regimens, and interventions aimed at managing diabetes and its vascular complications, including pharmacological studies and real-world applications.
  4. Epidemiological Studies:
    Conducting population-based studies to assess the incidence, prevalence, and risk factors associated with diabetes and its complications across different demographics.
  5. Biomarkers and Molecular Mechanisms:
    Identifying biomarkers and understanding the molecular pathways involved in diabetes and vascular dysfunction to facilitate early diagnosis and targeted therapy.
Recent publications in 'Diabetes & Vascular Disease Research' reveal significant trends and emerging themes that are reshaping the understanding of diabetes and its vascular implications. These themes reflect advancements in technology, evolving treatment paradigms, and a deeper understanding of disease mechanisms.
  1. Role of Novel Therapeutics:
    An increasing focus on the efficacy of novel diabetes medications, particularly sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, in reducing cardiovascular and renal risks associated with diabetes.
  2. Microvascular Complications and Inflammation:
    Emerging research is highlighting the role of inflammation in the development of microvascular complications, such as diabetic retinopathy and nephropathy, leading to new therapeutic targets.
  3. Integration of Technology in Diabetes Management:
    The use of continuous glucose monitoring systems and digital health technologies is trending, with research exploring their impact on glycemic control and patient outcomes.
  4. Psychosocial Factors in Diabetes Management:
    There is a growing recognition of the importance of psychological and social factors in diabetes management, with studies investigating how these factors influence disease progression and treatment adherence.
  5. Longitudinal and Cohort Studies:
    A trend towards conducting longitudinal studies that track diabetes progression and its vascular complications over time, providing insights into long-term outcomes and risk factors.

Declining or Waning

While certain areas of research maintain a robust presence in the journal, others appear to be declining in frequency or relevance. This decline may suggest shifts in research priorities or advancements in understanding that make some previously emphasized topics less prominent.
  1. Historical Cardiovascular Risk Factors:
    Research focusing on traditional cardiovascular risk factors in isolation, such as cholesterol levels or hypertension, appears to be waning as studies increasingly emphasize the interconnectivity between diabetes and broader health outcomes.
  2. Basic Science Approaches without Clinical Applications:
    There seems to be a decrease in purely basic science studies that do not directly translate to clinical practice or patient outcomes, as the journal shifts towards more translational research that impacts patient care.
  3. Single-Factor Studies:
    Studies that examine the effects of diabetes on vascular health in isolation without considering the multifactorial nature of these diseases are becoming less common, reflecting a trend towards a more holistic approach in research.

Similar Journals

Artery Research

Connecting researchers for groundbreaking discoveries in arterial science.
Publisher: BMCISSN: 1872-9312Frequency: 4 issues/year

Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.

DIABETOLOGIA

Elevating knowledge in diabetes management and treatment.
Publisher: SPRINGERISSN: 0012-186XFrequency: 12 issues/year

DIABETOLOGIA is a leading journal in the field of endocrinology and diabetes research, published by Springer since its inception in 1965. With an impactful presence in both Internal Medicine and Endocrinology, Diabetes and Metabolism, it is recognized in the Q1 quartile rankings for 2023, underscoring its significance and contribution to these disciplines. The journal holds impressive Scopus rankings, placing it in the top 5% of journals in its categories, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practices in diabetes care and management. DIABETOLOGIA publishes a range of peer-reviewed articles, original research, and reviews that address the latest scientific developments, clinical practices, and therapeutic innovations, contributing to the global discourse on diabetes and its related health implications. Although it does not offer Open Access options, its rigorous selection process guarantees the quality and relevance of the content, solidifying its position as a reliable reference for contemporary research. For those looking to stay at the forefront of diabetes science, DIABETOLOGIA is a vital communique in the ever-evolving landscape of medical research.

International Journal of Vascular Medicine

Exploring Innovations in Cardiovascular Medicine
Publisher: HINDAWI LTDISSN: 2090-2824Frequency: 1 issue/year

The International Journal of Vascular Medicine is a peer-reviewed, open access journal dedicated to advancing research and knowledge in the field of vascular medicine. Published by HINDAWI LTD and operating since 2010, this journal provides a platform for the dissemination of high-quality studies, reviews, and case reports related to cardiovascular health. Based in Egypt, the journal's comprehensive scope encompasses a range of topics within cardiology and cardiovascular medicine, with a current impact factor reflected by its Q3 ranking in 2023, positioning it among the noteworthy publications in its category. With a Scopus rank of 176 out of 387, the journal maintains a significant presence in the academic community, supported by a commitment to open access, ensuring that research is freely available to all stakeholders. Researchers, professionals, and students alike are encouraged to contribute to and engage with the International Journal of Vascular Medicine as it enhances the understanding and treatment of vascular diseases and promotes innovative practices within the field.

CLINICAL SCIENCE

Fostering Collaboration in Clinical Research Excellence
Publisher: PORTLAND PRESS LTDISSN: 0143-5221Frequency: 24 issues/year

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

ANGIOLOGY

Empowering Cardiologists with Cutting-Edge Insights
Publisher: SAGE PUBLICATIONS INCISSN: 0003-3197Frequency: 10 issues/year

ANGIOLOGY is a leading journal dedicated to the field of cardiology and cardiovascular medicine, published by SAGE Publications Inc. With a distinguished history dating back to 1950, this journal serves as an essential platform for the dissemination of cutting-edge research, innovative clinical practices, and emerging trends in cardiovascular health. Holding a respected Q2 ranking in the 2023 Scopus category for Cardiology and Cardiovascular Medicine, and positioned within the 74th percentile of its field, ANGIOLOGY is an invaluable resource for researchers, healthcare professionals, and students alike. While currently not an open-access journal, it offers subscription options to access comprehensive articles that aim to advance knowledge and improve patient care across various cardiovascular disciplines. The journal's commitment to fostering dialogue and sharing groundbreaking findings underscores its importance in the ongoing pursuit of cardiovascular excellence.

JOURNAL OF VASCULAR RESEARCH

Pioneering insights in cardiology and physiology.
Publisher: KARGERISSN: 1018-1172Frequency: 6 issues/year

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

Diabetology International

Elevating knowledge, enhancing diabetes care.
Publisher: SPRINGER JAPAN KKISSN: 2190-1678Frequency: 4 issues/year

Diabetology International, published by Springer Japan KK, is a leading journal dedicated to the field of diabetes research. With an ISSN of 2190-1678 and E-ISSN of 2190-1686, this journal plays a pivotal role in disseminating innovative studies and findings that advance understanding in endocrinology, diabetes, and metabolism. Its rigorous peer-review process ensures the publication of high-quality research articles, review papers, and clinical studies, making it a valuable resource for researchers, healthcare professionals, and students. The journal is indexed in Scopus and maintains respectable rankings in its categories, standing at Q3 in Endocrinology, Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. Furthermore, the journal facilitates collaborations and promotes the exchange of ideas from its base in Tokyo, Japan, helping to bridge the gap between academia and clinical practice. As it converges through the years from 2010 to 2024, Diabetology International remains committed to addressing the evolving challenges in diabetes care and research, supporting the global community's pursuit of knowledge in this crucial field.

International Journal of Angiology

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

Journal of Cardiovascular Development and Disease

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: MDPIISSN: Frequency: 12 issues/year

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

EJVES Vascular Forum

Empowering the Future of Vascular Surgery and Medicine
Publisher: ELSEVIERISSN: 2666-688XFrequency:

EJVES Vascular Forum, published by Elsevier, is a premier open access journal focusing on the interdisciplinary field of vascular surgery and cardiovascular medicine. Since its inception in 2001, the journal has provided a vital platform for the dissemination of high-quality research and innovative clinical practices, addressing critical issues in vascular health. With an ISSN of 2666-688X, it has gained recognition within its community, attaining a Q3 quartile ranking in both cardiology and surgery categories as of 2023, and showcasing its relevance and impact within the medical research landscape. Situated in the United Kingdom and accessible globally, the EJVES Vascular Forum invites contributions that foster collaboration and enhance knowledge in vascular surgery, making it an essential resource for researchers, professionals, and students alike. The journal's ranking within Scopus highlights its position among peers, adding further credence to its objectives of advancing science and improving patient care in the cardiovascular realm. By publishing rigorously peer-reviewed articles, the journal aims to be the go-to source of information and innovation for those dedicated to the progress of vascular health.